{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:15:59Z","timestamp":1790572559300,"version":"4.1.0"},"reference-count":52,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.2687","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T15:01:53Z","timestamp":1647442913000},"page":"e222687","source":"Crossref","is-referenced-by-count":40,"title":["Association of the Interaction Between Familial Hypercholesterolemia Variants and Adherence to a Healthy Lifestyle With Risk of Coronary Artery Disease"],"prefix":"10.1001","volume":"5","author":[{"given":"Akl C.","family":"Fahed","sequence":"first","affiliation":[{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxian","family":"Wang","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddh P.","family":"Patel","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezimamaka","family":"Ajufo","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, UT Southwestern Medical Center, Dallas, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri J.","family":"Maamari","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna G.","family":"Aragam","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna G.","family":"Brockman","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trish","family":"Vosburg","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Ellinor","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenney","family":"Ng","sequence":"additional","affiliation":[{"name":"Center for Computational Health, IBM Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Khera","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Medicine, UT Southwestern Medical Center, Dallas, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"issue":"6","key":"zoi220108r1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel.","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"zoi220108r2","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.jacc.2020.03.058","article-title":"Familial hypercholesterolemia: the most common monogenic disorder in humans.","volume":"75","author":"Kastelein","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"zoi220108r3","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia.","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"zoi220108r4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1161\/CIRCULATIONAHA.118.035658","article-title":"Whole-genome sequencing to characterize monogenic and polygenic contributions in patients hospitalized with early-onset myocardial infarction.","volume":"139","author":"Khera","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"zoi220108r5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3959","article-title":"Association of rare pathogenic DNA variants for familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and Lynch syndrome with disease risk in adults according to family history.","volume":"3","author":"Patel","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi220108r6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jamacardio.2019.5954","article-title":"Association of monogenic vs polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease.","volume":"5","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"6319","key":"zoi220108r7","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf7000","article-title":"Genetic identification of familial hypercholesterolemia within a single U.S. health care system.","volume":"354","author":"Abul-Husn","year":"2016","journal-title":"Science"},{"issue":"20","key":"zoi220108r8","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects.","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"45","key":"zoi220108r9","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"zoi220108r10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003120","article-title":"Developing and optimizing innovative tools to address familial hypercholesterolemia underdiagnosis: identification methods, patient activation, and cascade testing for familial hypercholesterolemia.","volume":"14","author":"Campbell-Salome","year":"2021","journal-title":"Circ Genom Precis Med"},{"issue":"3","key":"zoi220108r11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCGENETICS.116.001381","article-title":"Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States: data from the CASCADE-FH Registry.","volume":"9","author":"deGoma","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"issue":"8","key":"zoi220108r12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jacc.2018.02.085","article-title":"Cardiovascular disease prevention by diet modification: JACC Health Promotion Series.","volume":"72","author":"Yu","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"zoi220108r13","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jacc.2018.08.1037","article-title":"Healthy weight and obesity prevention: JACC Health Promotion Series.","volume":"72","author":"Lavie","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"zoi220108r14","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jacc.2018.08.2141","article-title":"Promoting physical activity and exercise: JACC Health Promotion Series.","volume":"72","author":"Fletcher","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"zoi220108r15","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"zoi220108r16","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s Strategic Impact Goal through 2020 and beyond.","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"zoi220108r17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.115.018585","article-title":"Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review.","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"24","key":"zoi220108r18","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease.","volume":"375","author":"Khera","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi220108r19","article-title":"Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.","author":"Marteau","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"7726","key":"zoi220108r20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data.","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"9596","key":"zoi220108r21","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"zoi220108r22","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1038\/s41467-020-17374-3","article-title":"Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions.","volume":"11","author":"Fahed","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"zoi220108r24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"zoi220108r25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003128","article-title":"Interactions between enhanced polygenic risk scores and lifestyle for cardiovascular disease, diabetes, and lipid levels.","volume":"14","author":"Ye","year":"2021","journal-title":"Circ Genom Precis Med"},{"issue":"8","key":"zoi220108r26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamacardio.2018.1717","article-title":"Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK Biobank Study.","volume":"3","author":"Said","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"19","key":"zoi220108r27","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1001\/jama.2018.14854","article-title":"The physical activity guidelines for Americans.","volume":"320","author":"Piercy","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"zoi220108r28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010038","article-title":"Cross-sectional study of diet, physical activity, television viewing and sleep duration in 233,110 adults from the UK Biobank; the behavioural phenotype of cardiovascular disease and type 2 diabetes.","volume":"6","author":"Cassidy","year":"2016","journal-title":"BMJ Open"},{"issue":"8","key":"zoi220108r29","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity.","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"issue":"8","key":"zoi220108r31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies.","volume":"38","author":"Price","year":"2006","journal-title":"Nat Genet"},{"issue":"12","key":"zoi220108r32","doi-asserted-by":"publisher","first-page":"e576","DOI":"10.1016\/S2468-2667(18)30200-7","article-title":"The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort.","volume":"3","author":"Foster","year":"2018","journal-title":"Lancet Public Health"},{"issue":"1","key":"zoi220108r33","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1097\/EDE.0000000000000752","article-title":"R function for additive interaction measures.","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"issue":"10","key":"zoi220108r34","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","article-title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"22","key":"zoi220108r35","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association.","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"zoi220108r36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.","volume":"171","author":"Watts","year":"2014","journal-title":"Int J Cardiol"},{"issue":"8","key":"zoi220108r37","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002146","article-title":"Healthcare utilization and patients\u2019 perspectives after receiving a positive genetic test for familial hypercholesterolemia.","volume":"11","author":"Jones","year":"2018","journal-title":"Circ Genom Precis Med"},{"issue":"7","key":"zoi220108r38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201cAll of Us\u201d Research Program.","volume":"381","author":"Denny","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi220108r39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ajhg.2018.07.009","article-title":"A model for genome-first care: returning secondary genomic findings to participants and their healthcare providers in a large research cohort.","volume":"103","author":"Schwartz","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"1","key":"zoi220108r40","doi-asserted-by":"crossref","DOI":"10.3390\/jpm6010002","article-title":"Building the Partners HealthCare Biobank at Partners personalized medicine: informed consent, return of research results, recruitment lessons and operational considerations.","volume":"6","author":"Karlson","year":"2016","journal-title":"J Pers Med"},{"issue":"1","key":"zoi220108r41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.002964","article-title":"Promise and peril of population genomics for the development of genome-first approaches in mendelian cardiovascular disease.","volume":"14","author":"Parikh","year":"2021","journal-title":"Circ Genom Precis Med"},{"issue":"22","key":"zoi220108r42","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","article-title":"Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study).","volume":"135","author":"P\u00e9rez de Isla","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"zoi220108r43","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1136\/hrt.2003.022764","article-title":"Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.","volume":"90","author":"Neil","year":"2004","journal-title":"Heart"},{"issue":"6","key":"zoi220108r44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/jim.2004.256.issue-6","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.","volume":"256","author":"Jansen","year":"2004","journal-title":"J Intern Med"},{"issue":"1","key":"zoi220108r45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis"},{"issue":"20","key":"zoi220108r46","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/eurheartj\/ehx004","article-title":"Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia.","volume":"38","author":"Tada","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"zoi220108r47","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.atherosclerosis.2003.12.027","article-title":"Exercise capacity and heart rate recovery as predictors of coronary heart disease events, in patients with heterozygous familial hypercholesterolemia.","volume":"173","author":"Pitsavos","year":"2004","journal-title":"Atherosclerosis"},{"issue":"24","key":"zoi220108r48","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and treatment of heterozygous familial hypercholesterolemia.","volume":"8","author":"McGowan","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"zoi220108r49","article-title":"Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.","author":"Malhotra","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"zoi220108r50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1756-0500-5-181","article-title":"No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trial.","volume":"5","author":"Broekhuizen","year":"2012","journal-title":"BMC Res Notes"},{"issue":"12","key":"zoi220108r51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050032","article-title":"Can multiple lifestyle behaviours be improved in people with familial hypercholesterolemia? results of a parallel randomised controlled trial.","volume":"7","author":"Broekhuizen","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"zoi220108r52","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population.","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"zoi220108r23","unstructured":"UK Biobank. Definitions of acute myocardial infarction and main myocardial infarction pathological types: UK Biobank phase 1 outcomes adjudication. Published August 2017. Accessed June 1, 2020. https:\/\/biobank.ndph.ox.ac.uk\/showcase\/showcase\/docs\/alg_outcome_mi.pdf"},{"key":"zoi220108r30","unstructured":"National Heart, Lung, and Blood Institute. The practical guide: identification, evaluation, and treatment of overweight and obesity in Adults. Published October 2000. Accessed April 28, 2021. https:\/\/www.nhlbi.nih.gov\/files\/docs\/guidelines\/prctgd_c.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2790163\/fahed_2022_oi_220108_1646844117.64105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T15:02:07Z","timestamp":1647442927000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2790163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.2687","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}